- Home
- / aTyr Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
aTyr Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.9
2024-08-06
Market Capitalization
$131.1 M
2024-08-06
Revenue
$190 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 422.0K | 10.5M | 10.4M | 353.0K | 235.0K | 190.0K | |||||
| General and administrative expense | 13.1M | 15.1M | 17.1M | 12.4M | 9.4M | 9.1M | 10.8M | 14.0M | 13.0M | 13.8M | 17.6M |
| Operating expense total | 47.6M | 57.9M | 47.1M | 32.8M | 23.4M | 26.4M | 56.8M | 68.1M | 77.8M | ||
| EBIT | (47.6M) | (57.9M) | (47.1M) | (32.8M) | (23.0M) | (15.9M) | (34.0M) | (46.4M) | (54.9M) | (67.9M) | (77.6M) |
| EBIT margin, % | -5445.0% | -152.2% | -446.8% | -28899.6% | -40856.3% | ||||||
| Interest expense | 386.0K | 65.0K | 1.1M | 1.7M | 172.0K | 137.0K | |||||
| Pre tax profit | (48.0M) | (57.9M) | (48.2M) | (34.5M) | (23.8M) | (16.2M) | (33.8M) | (45.3M) | (50.4M) | (64.0M) | (74.1M) |
| Income tax expense | (49.0K) | ||||||||||
| Net Income | (48.0M) | (57.9M) | (48.2M) | (34.5M) | (23.8M) | (16.2M) | (33.8M) | (45.3M) | (50.4M) | (64.0M) | (74.1M) |
| EPS | (1.6) | (0.9) | (0.8) |